Cohort of the Franco-European Multidisciplinary Institute of Endometriosis
Clinique Tivoli Ducos
15,000 participants
Feb 1, 2021
OBSERVATIONAL
Conditions
Summary
Endometriosis is a chronic benign gynecological condition affecting 5 to 10% of women of reproductive age, often responsible for pelvic pain, digestive symptoms, and infertility, leading to a significant reduction in quality of life. Despite its high prevalence, the long-term outcomes of different medical and surgical treatments remain poorly documented. The IFEMENDO study is a prospective, observational, single-center, non-interventional cohort conducted at the Endometriosis Center of Clinique Tivoli-Ducos in Bordeaux, France. The objective is to evaluate the long-term efficacy of various therapeutic strategies-both medical and surgical-in terms of symptom improvement, quality of life, recurrence, and fertility outcomes. Women with histologically or radiologically confirmed pelvic endometriosis are invited to participate. Data are collected through standardized questionnaires at baseline and at 1, 3, 5, 7, and 10 years after inclusion, either via the secure NO ENDO online platform or in paper form. The study will contribute to a better understanding of the natural history of endometriosis and the long-term effectiveness of different treatment approaches, ultimately supporting improvements in clinical management and patient care.
Eligibility
Inclusion Criteria3
- Women aged >18 years
- Women with histologically or radiologically confirmed deep endometriosis (and/or) infiltrating the colon and/or rectum
- Women affiliated with the social security system
Exclusion Criteria2
- Refusal to participate
- Patients under guardianship or curatorship, or deprived of liberty
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OBSERVATIONAL STUDY
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07243587